-+ 0.00%
-+ 0.00%
-+ 0.00%

NeuroOne Medical Technologies Reports Preliminary FY25 Results Of $9.1M Product Revenue And $6.6M Cash On Hand

Benzinga·10/06/2025 20:40:07
Listen to the news

 

Preliminary Results

 

On October 6, 2024, the Company reported the following preliminary unaudited fiscal year 2025 financial and operational results:

 

  Achieved annual total product revenue of approximately $9.1 million.

 

  Cash and cash equivalents of approximately $6.6 million at September 30, 2025.